Australian medtech Navi raises $A6.8 million to commercialise breakthrough paediatric technology in the US
MELBOURNE, Australia and BOSTON, July 29, 2026 /PRNewswire/ -- Melbourne- and Boston-based medical device company Navi Medical Technologies has closed a $A6.8 million capital raise to commercialise its breakthrough paediatric vascular access...
From China Mobile's Call Upgrade to the Commercial Launch of "Calling + AI" by Leading Operators: AI Is Reshaping the Value of Native Calling
BEIJING, July 25, 2026 /PRNewswire/ -- On June 15, 2026, China Mobile announced a comprehensive upgrade to its traditional calling services, ushering in a next-generation calling experience defined by HD, intelligence, and security. This milestone...
STRADVISION Sets New Global Benchmark for ADAS with Launch of Production-Ready Integrated Perception Platform
Strategic collaboration with leading Physical AI developer delivers a turnkey solution for accelerated Level 2+ vehicle integration SEOUL, South Korea, May 12, 2026 /PRNewswire/ -- STRADVISION, a global pioneer in AI-powered vision perception...
4DMedical receives CE Mark for CT:VQ™, enabling commercial launch across the European Union
In a separate announcement made today, the Company also secured A$83 million in private placement funding to support growth initiatives, including European expansion. MELBOURNE, Australia, March 31, 2026 /PRNewswire/ -- 4DMedical Limited (ASX:4DX),...
Everest Medicines Announces Commercial Launch and First Prescription for VELSIPITY® in Mainland China
SHANGHAI, March 9, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today...
Telin Partners with IPification to Launch Telin Mobile Network Verification - Revolutionizing Digital Identity at the Network Level
JAKARTA, Indonesia, Feb. 24, 2026 /PRNewswire/ -- PT Telekomunikasi Indonesia International (Telin), a leading global digital connectivity and infrastructure provider, announced a strategic partnership with IPification to launch and commercialize...
REPROCELL Launches StemEdit - Clinical Gene Editing Services and New iPSC Lines Using AI-Designed editing tools
BELTSVILLE, Md., Jan. 29, 2026 /PRNewswire/ -- REPROCELL today announced the commercial launch of StemEdit, its clinical gene editing services and new gene-edited iPSC product lines leveraging OpenCRISPR-1™, an AI-designed genome editing system...
OMOWAY Raises Eight-Figure USD to Scale the World's First Mass-Produced Self-Balancing E-Motorcycle
SINGAPORE, Jan. 14, 2026 /PRNewswire/ -- OMOWAY, a pioneer in two-wheeled smart mobility, has successfully closed consecutive Pre-A and Pre-A+ funding rounds, raising tens of millions of US dollars. The investment was led by HONGSHAN and ROCKET...
Enhanced Genetype colorectal cancer risk test released - supports earlier disease detection and ColoSTAT® targeting
MELBOURNE, Australia, Jan. 14, 2026 /PRNewswire/ -- Rhythm Biosciences Ltd ('RHY', the 'Company' or the 'Group') (ASX: RHY), a transformative, predictive cancer diagnostics technology company is pleased to announce the commercial launch of its...
Ark Biopharmaceutical Receives China Marketing Authorization for Aizhida for the Treatment of ADHD
SHANGHAI, Jan. 8, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that China's National Medical Products Administration (NMPA) has approved the New Drug Application for Serdexmethylphenidate Chloride and...